Neurogene (NGNE) EPS (Basic) (2013 - 2026)

Neurogene (NGNE) posted EPS (Basic) of -$1.72 for Q1 2026, down 47.27% on a QoQ basis from -$1.17 in Q4 2025, and down 53.93% year-over-year from -$3.73 in Q1 2025.

Neurogene (NGNE) EPS (Basic) (2013 - 2026) Analysis & Trends

Neurogene's EPS (Basic) history runs 14 years deep, the most recent figure standing at -$1.72 for Q1 2026.

  • Quarterly EPS (Basic) fell 53.93% year-over-year to -$1.72 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$5.01 (up 11.2% YoY) and the FY2025 annual result came in at -$10.86, down 0.86% from the prior year.
  • EPS (Basic) was -$1.72 for Q1 2026 at Neurogene, down from -$1.17 in the prior quarter.
  • Across five years, EPS (Basic) topped out at -$1.12 in Q1 2025 and bottomed at -$28.37 in Q4 2023.
  • A 5-year average of -$5.38 and a median of -$2.88 in 2024 frame the typical range for EPS (Basic).
  • Annual changes were most pronounced in 2023 — EPS (Basic) slumped 57.18% — and 2024, when it soared 95.36%.
  • Neurogene's EPS (Basic) stood at -$18.05 in 2022, then plunged by 57.18% to -$28.37 in 2023, then soared by 95.36% to -$1.32 in 2024, then grew by 11.41% to -$1.17 in 2025, then sank by 47.27% to -$1.72 in 2026.
  • Business Quant data shows NGNE's EPS (Basic) at -$1.72 in Q1 2026, -$1.17 in Q4 2025, and -$1.13 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EPS (Basic) (Qtr)
1 Oculis Holding AG 67,072.09 Bn 67,072.09 Bn - 0.00
2 Nanobiotix 1,894.61 Bn 1,894.55 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - 0.00
4 BeOne Medicines 471.64 Bn 466.85 Bn 1.35 Bn 0.16
5 Vertex Pharmaceuticals 121.72 Bn 114.47 Bn 2.59 Bn 4.06
6 Regeneron Pharmaceuticals 68.28 Bn 59.52 Bn 3.31 Bn 6.99
7 Belite Bio 61.40 Bn 61.40 Bn - 0.00
8 Argenx Se 56.94 Bn 56.94 Bn 1.18 Bn 5.90
9 Revolution Medicines 37.37 Bn 37.37 Bn - -2.29
10 Neurogene 776.69 Mn 776.69 Mn - -1.72

Historic Data

Download Data
DateValue
Mar 31, 2026 -1.72
Dec 31, 2025 -1.17
Sep 30, 2025 -1.13
Jun 30, 2025 -1.17
Mar 31, 2025 -1.12
Dec 31, 2024 -1.32
Sep 30, 2024 -2.38
Jun 30, 2024 -1.87
Mar 31, 2024 -2.88
Dec 31, 2023 -28.37
Sep 30, 2023 -5.25
Jun 30, 2023 -4.23
Mar 31, 2023 -4.42
Dec 31, 2022 -18.05
Sep 30, 2022 -4.96
Jun 30, 2022 -5.78
Mar 31, 2022 -5.58
Dec 31, 2021 -14.67
Sep 30, 2021 -12.28
Jun 30, 2021 -15.05